Sargent Bickham Lagudis’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$5.2K Hold
150
﹤0.01% 799
2022
Q3
$4K Hold
150
﹤0.01% 794
2022
Q2
$4K Hold
150
﹤0.01% 810
2022
Q1
$6K Hold
150
﹤0.01% 765
2021
Q4
$7K Hold
150
﹤0.01% 752
2021
Q3
$6K Hold
150
﹤0.01% 781
2021
Q2
$7K Hold
150
﹤0.01% 754
2021
Q1
$7K Hold
150
﹤0.01% 750
2020
Q4
$5K Hold
150
﹤0.01% 730
2020
Q3
$3K Hold
150
﹤0.01% 692
2020
Q2
$2K Hold
150
﹤0.01% 697
2020
Q1
$1K Hold
150
﹤0.01% 723
2019
Q4
$3K Hold
150
﹤0.01% 729
2019
Q3
$3K Hold
150
﹤0.01% 653
2019
Q2
$4K Hold
150
﹤0.01% 672
2019
Q1
$2K Hold
150
﹤0.01% 744
2018
Q4
$2K Hold
150
﹤0.01% 709
2018
Q3
$6K Hold
150
﹤0.01% 663
2018
Q2
$7K Sell
150
-16
-10% -$908 ﹤0.01% 624
2018
Q1
$10K Hold
166
﹤0.01% 569
2017
Q4
$13K Hold
166
﹤0.01% 560
2017
Q3
$14K Hold
166
﹤0.01% 556
2017
Q2
$11K Sell
166
-50
-23% -$3.4K ﹤0.01% 555
2017
Q1
$16K Hold
216
﹤0.01% 516
2016
Q4
$13K Buy
+216
New +$11.4K ﹤0.01% 521

Other funds holding ADNT

Sargent Bickham Lagudis's ADNT Position: Q4 2022 in Review

Sargent Bickham Lagudis held its Adient (ADNT) position steady in Q4 2022 at 150 shares worth $5.2K. The position accounts for ﹤0.01% of the portfolio, ranked #799.

Sargent Bickham Lagudis first reported a position in ADNT in Q4 2016 and has held it in 25 quarters since. The position peaked at $16K in Q1 2017. 273 funds tracked by Wall St. Rank hold ADNT as of Q4 2022.

  • Sargent Bickham Lagudis held 150 shares of Adient worth $5.2K as of Q4 2022.
  • Sargent Bickham Lagudis left its Adient share count unchanged in Q4 2022.
  • Adient made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #799 holding.
  • Sargent Bickham Lagudis first reported a position in Adient in Q4 2016 and has held it in 25 quarters since.
  • Sargent Bickham Lagudis's Adient position peaked at $16K in Q1 2017.
  • 273 funds tracked by Wall St. Rank held Adient as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.